<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trop Med Int Health</journal-id><journal-id journal-id-type="iso-abbrev">Trop. Med. Int. Health</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1365-3156</journal-id><journal-id journal-id-type="publisher-id">TMI</journal-id><journal-title-group><journal-title>Tropical Medicine &#x00026; International Health</journal-title></journal-title-group><issn pub-type="ppub">1360-2276</issn><issn pub-type="epub">1365-3156</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27383558</article-id><article-id pub-id-type="pmc">5031222</article-id><article-id pub-id-type="doi">10.1111/tmi.12748</article-id><article-id pub-id-type="publisher-id">TMI12748</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research Papers</subject></subj-group></article-categories><title-group><article-title>Appropriate targeting of artemisinin&#x02010;based combination therapy by community health workers using malaria rapid diagnostic tests: findings from randomized trials in two contrasting areas of high and low malaria transmission in south&#x02010;western Uganda</article-title><alt-title alt-title-type="left-running-head">R. Ndyomugyenyi <italic>et al</italic>.</alt-title></title-group><contrib-group><contrib id="tmi12748-cr-0001" contrib-type="author"><name><surname>Ndyomugyenyi</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="tmi12748-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="tmi12748-cr-0002" contrib-type="author"><name><surname>Magnussen</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="tmi12748-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="tmi12748-cr-0003" contrib-type="author"><name><surname>Lal</surname><given-names>Sham</given-names></name><xref ref-type="aff" rid="tmi12748-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="tmi12748-cr-0004" contrib-type="author"><name><surname>Hansen</surname><given-names>Kristian</given-names></name><xref ref-type="aff" rid="tmi12748-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="tmi12748-cr-0005" contrib-type="author" corresp="yes"><name><surname>Clarke</surname><given-names>Si&#x000e2;n E.</given-names></name><xref ref-type="aff" rid="tmi12748-aff-0003">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="tmi12748-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Vector Control Division</named-content><institution>Ministry of Health</institution><named-content content-type="city">Kampala</named-content><country country="UG">Uganda</country></aff><aff id="tmi12748-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Centre for Medical Parasitology</named-content><named-content content-type="organisation-division">Department for Immunology and Microbiology</named-content><named-content content-type="organisation-division">Faculty of Health and Medical Sciences</named-content><institution>University of Copenhagen</institution><named-content content-type="city">Copenhagen</named-content><country country="DK">Denmark</country></aff><aff id="tmi12748-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">Department of Disease Control</named-content><named-content content-type="organisation-division">Faculty of Infectious and Tropical Diseases</named-content><institution>London School of Hygiene and Tropical Medicine</institution><named-content content-type="city">London</named-content><country country="GB">UK</country></aff><aff id="tmi12748-aff-0004"><label><sup>4</sup></label><named-content content-type="organisation-division">Department of Global Health and Development</named-content><named-content content-type="organisation-division">Faculty of Public Health and Policy</named-content><institution>London School of Hygiene and Tropical Medicine</institution><named-content content-type="city">London</named-content><country country="GB">UK</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Corresponding Author Si&#x000e2;n E. Clarke</bold>, Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. E&#x02010;mail: <email>Sian.Clarke@lshtm.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2016</year></pub-date><volume>21</volume><issue>9</issue><issue-id pub-id-type="doi">10.1111/tmi.2016.21.issue-9</issue-id><fpage>1157</fpage><lpage>1170</lpage><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 John Wiley & Sons Ltd <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2016 The Authors. <italic>Tropical Medicine &#x00026; International Health</italic> Published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:TMI-21-1157.pdf"/><abstract id="tmi12748-abs-0001"><title>Abstract</title><sec id="tmi12748-sec-0001"><title>Objective</title><p>To compare the impact of malaria rapid diagnostic tests (<styled-content style="fixed-case">mRDT</styled-content>s), used by community health workers (<styled-content style="fixed-case">CHW</styled-content>s), on the proportion of children &#x0003c;5 years of age receiving appropriately targeted treatment with artemisinin&#x02010;based combination therapy (ACT), vs. presumptive treatment.</p></sec><sec id="tmi12748-sec-0002"><title>Methods</title><p>Cluster&#x02010;randomized trials were conducted in two contrasting areas of moderate&#x02010;to&#x02010;high and low malaria transmission in rural Uganda. Each trial examined the effectiveness of <styled-content style="fixed-case">mRDT</styled-content>s in the management of malaria and targeting of <styled-content style="fixed-case">ACT</styled-content>s by <styled-content style="fixed-case">CHW</styled-content>s comparing two diagnostic approaches: (i) presumptive clinical diagnosis of malaria [control arm] and (ii) confirmatory diagnosis with <styled-content style="fixed-case">mRDT</styled-content>s followed by <styled-content style="fixed-case">ACT</styled-content> treatment for positive patients [intervention arm], with village as the unit of randomisation. Treatment decisions by <styled-content style="fixed-case">CHW</styled-content>s were validated by microscopy on a reference blood slide collected at the time of consultation, to compare the proportion of children &#x0003c;5 years receiving appropriately targeted <styled-content style="fixed-case">ACT</styled-content> treatment, defined as patients with microscopically&#x02010;confirmed presence of parasites in a peripheral blood smear receiving artemether&#x02010;lumefantrine or rectal artesunate, and patients with no malaria parasites not given ACT.</p></sec><sec id="tmi12748-sec-0003"><title>Results</title><p>In the moderate&#x02010;to&#x02010;high transmission area, <styled-content style="fixed-case">ACT</styled-content> treatment was appropriately targeted in 79.3% (520/656) of children seen by <styled-content style="fixed-case">CHW</styled-content>s using <styled-content style="fixed-case">mRDT</styled-content>s to diagnose malaria, <italic>vs</italic>. 30.8% (215/699) of children seen by <styled-content style="fixed-case">CHW</styled-content>s using presumptive diagnosis (<italic>P</italic> &#x0003c; 0.001). In the low transmission area, 90.1% (363/403) children seen by <styled-content style="fixed-case">CHW</styled-content>s using <styled-content style="fixed-case">mRDT</styled-content>s received appropriately targeted <styled-content style="fixed-case">ACT</styled-content> treatment <italic>vs</italic>. 7.8% (64/817) seen by <styled-content style="fixed-case">CHW</styled-content>s using presumptive diagnosis (<italic>P</italic> &#x0003c; 0.001). Low <styled-content style="fixed-case">mRDT</styled-content> sensitivity in children with low&#x02010;density parasitaemia (&#x0003c;200 parasites/<italic>&#x003bc;</italic>l) was identified as a potential concern.</p></sec><sec id="tmi12748-sec-0004"><title>Conclusion</title><p>When equipped with <styled-content style="fixed-case">mRDT</styled-content>s, <styled-content style="fixed-case">ACT</styled-content> treatments delivered by <styled-content style="fixed-case">CHW</styled-content>s are more accurately targeted to children with malaria parasites. <styled-content style="fixed-case">mRDT</styled-content> use could play an important role in reducing overdiagnosis of malaria and improving fever case management within <styled-content style="fixed-case">iCCM</styled-content>, in both moderate&#x02010;to&#x02010;high and low transmission areas. Nonetheless, missed treatments due to the low sensitivity of current <styled-content style="fixed-case">mRDT</styled-content>s in patients with low parasite density are a concern. For community&#x02010;based treatment in areas of low transmission and/or non&#x02010;immune populations, presumptive treatment of all fevers as malaria may be advisable, until more sensitive diagnostic assays, suitable for routine use by <styled-content style="fixed-case">CHW</styled-content>s in remote settings, become available.</p></sec></abstract><trans-abstract xml:lang="fr" abstract-type="main" id="tmi12748-abs-0002"><sec id="tmi12748-sec-1001" xml:lang="fr"><title>Objectif</title><p xml:lang="fr">Comparer l'impact des tests de diagnostic rapide (TDR) du paludisme, utilis&#x000e9;s par les agents de sant&#x000e9; communautaires (ASC), sur la proportion d'enfants &#x0003c;5 ans qui re&#x000e7;oivent un traitement de combinaison &#x000e0; base d'art&#x000e9;misinine (ACT) cibl&#x000e9; de mani&#x000e8;re appropri&#x000e9;e pour le traitement pr&#x000e9;somptif.</p></sec><sec id="tmi12748-sec-1002" xml:lang="fr"><title>M&#x000e9;thodes</title><p xml:lang="fr">Des essais randomis&#x000e9;s en grappes ont &#x000e9;t&#x000e9; men&#x000e9;s dans deux zones rurales contrast&#x000e9;es de transmission mod&#x000e9;r&#x000e9;e &#x000e0; &#x000e9;lev&#x000e9;e et de transmission faible du paludisme en Ouganda. Chaque essai a examin&#x000e9; l'efficacit&#x000e9; des TDR dans la prise en charge du paludisme et le ciblage de l'ACT par les ASC en comparant deux approches diagnostiques: (1) le diagnostic pr&#x000e9;somptif clinique du paludisme [bras t&#x000e9;moin] et (2) le diagnostic de confirmation avec les TDR suivi d'un traitement ACT pour les patients positifs [bras d'intervention]; avec le village comme unit&#x000e9; de randomisation. Les d&#x000e9;cisions de traitement par les ASC ont &#x000e9;t&#x000e9; valid&#x000e9;es par la microscopie sur un frottis de sang de r&#x000e9;f&#x000e9;rence recueilli au moment de la consultation, pour comparer la proportion d'enfants &#x0003c;5 ans qui re&#x000e7;oivent un traitement ACT cibl&#x000e9; de fa&#x000e7;on appropri&#x000e9;e, d&#x000e9;fini comme les patients avec une pr&#x000e9;sence de parasites confirm&#x000e9;e microscopiquement dans un frottis de sang p&#x000e9;riph&#x000e9;rique, recevant un ACT ou de l'art&#x000e9;sunate par voie rectale, et les patients sans parasites du paludisme qui ne re&#x000e7;oivent pas d'ACT.</p></sec><sec id="tmi12748-sec-1003" xml:lang="fr"><title>R&#x000e9;sultats</title><p xml:lang="fr">Dans la zone de transmission mod&#x000e9;r&#x000e9;e &#x000e0; &#x000e9;lev&#x000e9;e, le traitement ACT a &#x000e9;t&#x000e9; cibl&#x000e9; de mani&#x000e8;re appropri&#x000e9;e chez 79,3% (520/656) des enfants vus par les ASC en utilisant les TDR pour diagnostiquer le paludisme, contre 30,8% (215/699) des enfants vus par les ASC en utilisant du diagnostic pr&#x000e9;somptif (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0,001). Dans la zone de transmission faible, 90,1% (363/403) des enfants vus par les ASC utilisant les TDR ont re&#x000e7;u de mani&#x000e8;re appropri&#x000e9;e le traitement cibl&#x000e9; ACT contre 7,8% (64/817) des enfants vus par les ASC en utilisant le diagnostic pr&#x000e9;somptif (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0,001). Une sensibilit&#x000e9; faible pour les TDR chez les enfants avec une faible densit&#x000e9; de parasit&#x000e9;mie (&#x0003c;200 parasites/&#x003bc;l) a &#x000e9;t&#x000e9; identifi&#x000e9;e comme un probl&#x000e8;me potentiel.</p></sec><sec id="tmi12748-sec-1004" xml:lang="fr"><title>Conclusion</title><p xml:lang="fr">Lorsqu&#x02019;&#x000e9;quip&#x000e9;s de TDR, les traitements ACT d&#x000e9;livr&#x000e9;s par les ASC sont cibl&#x000e9;s avec plus de pr&#x000e9;cision aux enfants avec des parasites du paludisme. L'utilisation des TDR pourrait jouer un r&#x000f4;le important dans la r&#x000e9;duction du surdiagnostic du paludisme et dans l'am&#x000e9;lioration de la prise en charge des cas de fi&#x000e8;vres au sein de la prise en charge int&#x000e9;gr&#x000e9;e communautaire des cas, &#x000e0; la fois dans les deux zones de transmission mod&#x000e9;r&#x000e9;e &#x000e0; &#x000e9;lev&#x000e9;e et faible. N&#x000e9;anmoins, les traitements manqu&#x000e9;s en raison de la faible sensibilit&#x000e9; des TDR actuels chez les patients pr&#x000e9;sentant une densit&#x000e9; parasitaire faible restent une pr&#x000e9;occupation. Pour le traitement &#x000e0; base communautaire dans les zones de faible transmission et/ou &#x000e0; populations non immunes, le traitement pr&#x000e9;somptif de toutes les fi&#x000e8;vres comme &#x000e9;tant le paludisme peut &#x000ea;tre conseill&#x000e9;, jusqu&#x02019;&#x000e0; ce que des tests de diagnostic plus sensibles, convenant &#x000e0; une utilisation de routine par les ASC dans des r&#x000e9;gions &#x000e9;loign&#x000e9;es, deviennent disponibles.</p></sec></trans-abstract><trans-abstract xml:lang="es" abstract-type="main" id="tmi12748-abs-0003"><sec id="tmi12748-sec-1005" xml:lang="es"><title>Objetivo</title><p xml:lang="es">Comparar el impacto de las pruebas de diagn&#x000f3;stico r&#x000e1;pido de malaria (PDRms) utilizadas por trabajadores sanitarios comunitarios (TSC) sobre la proporci&#x000f3;n de ni&#x000f1;os &#x0003c;5 a&#x000f1;os que recibieron adecuadamente la terapia de combinaci&#x000f3;n basada en la artemisinina (TCA), comparado con tratamiento presuntivo.</p></sec><sec id="tmi12748-sec-1006" xml:lang="es"><title>M&#x000e9;todos</title><p xml:lang="es">Se realizaron ensayos aleatorizados en conglomerados en dos &#x000e1;reas rurales contrastables, con intensidades de transmisi&#x000f3;n de malaria moderadamente&#x02010;alta y baja de Uganda. Cada ensayo examin&#x000f3; la efectividad de PDRms en el manejo de la malaria y la elecci&#x000f3;n de TCA por TSC comparando dos metodolog&#x000ed;as diagn&#x000f3;sticas: (1) diagn&#x000f3;stico cl&#x000ed;nico presuntivo de malaria [brazo control] y (2) diagn&#x000f3;stico confirmatorio con PDRms seguido por tratamiento con TCA para pacientes positivos [brazo de intervenci&#x000f3;n]; con el poblado como unidad de aleatorizaci&#x000f3;n. Las decisiones sobre el tratamiento por los TSCs se validaron mediante microscop&#x000ed;a de extensiones de sangre de referencia recogidas en el momento de la consulta, para comparar la proporci&#x000f3;n de ni&#x000f1;os &#x0003c;5 a&#x000f1;os recibiendo un TCA adecuadamente elegido, (definidos como pacientes con confirmaci&#x000f3;n microsc&#x000f3;pica de presencia de par&#x000e1;sitos en una extensi&#x000f3;n de sangre perif&#x000e9;rica y recibiendo tratamiento con TCA o artesunato rectal), y aquellos sin par&#x000e1;sitos de malaria que no recibieron TCA.</p></sec><sec id="tmi12748-sec-1007" xml:lang="es"><title>Resultados</title><p xml:lang="es">En el &#x000e1;rea de transmisi&#x000f3;n moderadamente&#x02010;alta, el tratamiento con TCA estaba apropiadamente elegido para un 79.3% (520/656) de los ni&#x000f1;os visitados por los TSCs utilizando PDRms para diagnosticar la malaria, vs. 30.8% (215/699) de los ni&#x000f1;os visitados por TSCs y utilizando diagn&#x000f3;stico presuntivo (<italic>P&#x000a0;</italic>&#x0003c;&#x000a0;0.001). En el &#x000e1;rea de baja transmisi&#x000f3;n, 90.1% (363/403) de los ni&#x000f1;os visitados por TSCs utilizando PDRms recibieron un tratamiento con TCA elegido apropiadamente vs. 7.8% (64/817) de los visitados por TSCs utilizando un diagn&#x000f3;stico presuntivo (<italic>P&#x000a0;</italic>&#x0003c;&#x000a0;0.001). Se identific&#x000f3; como una preocupaci&#x000f3;n potencial la baja sensibilidad a las PDRms en ni&#x000f1;os con una parasitemia de baja intensidad.</p></sec><sec id="tmi12748-sec-1008" xml:lang="es"><title>Conclusi&#x000f3;n</title><p xml:lang="es">Con el uso de PDRms, los tratamientos con TCA entregados por TSCs son m&#x000e1;s precisos en ni&#x000f1;os con par&#x000e1;sitos de malaria. Los PDRms podr&#x000ed;an jugar un papel importante para reducir el sobre diagn&#x000f3;stico de malaria y mejorar el manejo de casos de fiebre dentro del iCCM, tanto en &#x000e1;reas de transmisi&#x000f3;n moderada&#x02010;a&#x02010;alta como de baja transmisi&#x000f3;n. Sin embargo, los tratamientos perdidos en pacientes con una baja densidad de par&#x000e1;sitos, debido a la baja sensibilidad de los PDRms actualmente disponibles, son preocupantes. Para tratamientos basados en la comunidad en &#x000e1;reas de baja intensidad de transmisi&#x000f3;n y/o poblaciones no inmunes, el tratamiento presuntivo como malaria de todas las fiebres ser&#x000ed;a recomendable hasta que haya disponibilidad de pruebas diagn&#x000f3;sticas m&#x000e1;s sensibles, y adecuadas para un uso rutinario por TSCs en emplazamientos remotos.</p></sec></trans-abstract><kwd-group kwd-group-type="author-generated"><kwd id="tmi12748-kwd-0013">Rapid diagnostic test (<styled-content style="fixed-case">RDT</styled-content>)</kwd><kwd id="tmi12748-kwd-0014">artemisinin&#x02010;based combination therapy (<styled-content style="fixed-case">ACT</styled-content>)</kwd><kwd id="tmi12748-kwd-0015">community health workers (<styled-content style="fixed-case">CHW</styled-content>s)</kwd><kwd id="tmi12748-kwd-0016">appropriately targeted treatment</kwd><kwd id="tmi12748-kwd-0017">Uganda</kwd><kwd id="tmi12748-kwd-0018">community case management</kwd></kwd-group><kwd-group kwd-group-type="author-generated" xml:lang="fr"><kwd id="tmi12748-kwd-0001">test de diagnostic rapide (<styled-content style="fixed-case">TDR</styled-content>)</kwd><kwd id="tmi12748-kwd-0002">combinaison th&#x000e9;rapeutique &#x000e0; base d'art&#x000e9;misinine (<styled-content style="fixed-case">ACT</styled-content>)</kwd><kwd id="tmi12748-kwd-0003">agents de sant&#x000e9; communautaire (<styled-content style="fixed-case">ASC</styled-content>)</kwd><kwd id="tmi12748-kwd-0004">traitement cibl&#x000e9; appropri&#x000e9;</kwd><kwd id="tmi12748-kwd-0005">Ouganda</kwd><kwd id="tmi12748-kwd-0006">prise en charge communautaire des cas</kwd></kwd-group><funding-group><award-group><funding-source>ACT Consortium</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Wellcome Trust</funding-source></award-group></funding-group><funding-group><award-group><funding-source>Research Career Development Fellowship</funding-source><award-id>084933</award-id></award-group></funding-group><counts><page-count count="14"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>tmi12748</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:21.09.2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="tmi12748-sec-0005"><title>Introduction</title><p>Early diagnosis and effective case management is a central component of the current malaria control strategy <xref rid="tmi12748-bib-0001" ref-type="ref">1</xref>, <xref rid="tmi12748-bib-0002" ref-type="ref">2</xref>, yet millions live at or beyond the periphery of the health system. Improving access to care for childhood infectious diseases by bringing treatment closer to the community is an attractive option, especially in rural settings where distance, cost and infrastructural challenges of primary healthcare centres limit access to expert services <xref rid="tmi12748-bib-0003" ref-type="ref">3</xref>. Targeting artemisinin&#x02010;based combination therapy (ACT) to those who are parasitologically confirmed malaria cases is critical in reducing misdiagnosis and overuse of these expensive drugs and may play an important role in the financial sustainability of community&#x02010;based programmes <xref rid="tmi12748-bib-0004" ref-type="ref">4</xref>, <xref rid="tmi12748-bib-0005" ref-type="ref">5</xref>, <xref rid="tmi12748-bib-0006" ref-type="ref">6</xref>. The World Health Organization (WHO) now recommends universal access to malaria diagnostics <xref rid="tmi12748-bib-0007" ref-type="ref">7</xref>, and at the moment, antigen&#x02010;based rapid diagnostic tests (mRDTs) are the only feasible test at community level. The case for their use rather than presumptive treatment is strong, due to lack of accurate algorithm&#x02010;based diagnosis <xref rid="tmi12748-bib-0008" ref-type="ref">8</xref> and negative consequences of overuse of antimalarials <xref rid="tmi12748-bib-0006" ref-type="ref">6</xref>. Although there is evidence that mRDTs and ACTs can be successfully deployed at community level <xref rid="tmi12748-bib-0009" ref-type="ref">9</xref>, <xref rid="tmi12748-bib-0010" ref-type="ref">10</xref>, there is little information on whether their use improves the targeting of ACTs to malaria patients at that level, especially in low transmission settings. We conducted a cluster&#x02010;randomized controlled trial to compare the impact of mRDTs, used by CHWs, on the proportion of children &#x0003c;5 years of age receiving appropriately targeted treatment with ACT, <italic>vs</italic>. presumptive treatment. The study took place in two different malaria transmission settings in rural Uganda to provide evidence to optimise use of ACTs and mRDTs within programmes of integrated community case management (iCCM) that are currently being scaled up in Uganda and other countries.</p></sec><sec id="tmi12748-sec-0006"><title>Materials and methods</title><sec id="tmi12748-sec-0007"><title>Study area</title><p>The study was conducted in Rukungiri District, south&#x02010;western Uganda, inhabited by the Bahororo and Bakiga ethnic groups, whose main occupation is subsistence farming. Anaemia among under&#x02010;fives in south&#x02010;western Uganda is estimated at 40%, and in other regions of the country, it ranges from 57% to 74% <xref rid="tmi12748-bib-0011" ref-type="ref">11</xref>. The district was selected for the study due to its wide altitudinal range between 980 and 2160 m above sea level, resulting in diverse malaria transmission patterns within the same district. Two subcounties with contrasting malaria transmission were selected as trial sites: Bwambara subcounty, a lower altitudinal area bordered by Lake Edward, which is meso&#x02010;endemic for malaria with moderate&#x02010;to&#x02010;high transmission, and Nyakishenyi subcounty, an epidemic&#x02010;prone highland area with low transmission, which is hypo&#x02010;endemic for malaria.</p><p>All villages in the two subcounties were invited to participate in the trial: 63 villages in Bwambara, ranging between 981&#x02013;1203 m, and 64 villages in Nyakishenyi, ranging between 1064&#x02013;2157 m. A public meeting was held in each eligible community to explain the purpose of the research, and community members were asked to identify 2&#x02013;3 CHWs per village for training. Written informed consent to take part in the trial was sought from community leaders and all CHWs selected for training, of whom more than 50% had previously worked in the home&#x02010;based management of fever (HBMF) programme that was defunct at the time of the study.</p></sec><sec id="tmi12748-sec-0008"><title>Trial design</title><p>A cluster&#x02010;randomized two&#x02010;arm trial design was used to compare the effectiveness of mRDTs used by CHWs to diagnose and treat malaria with ACT [intervention] to presumptive diagnosis and treatment of malaria with ACT [control]. The unit of randomisation was the village, with all CHWs in the same village receiving the same type of training. Within each transmission area (subcounty), villages were randomly allocated, using a random number table in Epi Info, to either the intervention (mRDT) or control (presumptive treatment) arm.</p><p>Community health workers in both arms of the trial were trained in recognising signs and symptoms of malaria, how to administer antimalarial treatment and when to refer (Figure <xref rid="tmi12748-fig-0001" ref-type="fig">1</xref>, Table <xref rid="tmi12748-tbl-0001" ref-type="table-wrap">1</xref>). Half of the villages were randomized to receive additional training in malaria diagnosis using mRDTs (intervention villages) and trained to only give antimalarial treatment with ACT after a positive test result, with the aim to increase the proportion of children receiving appropriately targeted treatment.</p><fig fig-type="Figure" xml:lang="en" id="tmi12748-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Design of an intervention to support use of malaria diagnostic tests (<styled-content style="fixed-case">mRDT</styled-content>s) by community health workers in Uganda.</p></caption><graphic id="nlm-graphic-1" xlink:href="TMI-21-1157-g001"/></fig><table-wrap id="tmi12748-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Training and supporting interventions for community health workers in the intervention and control arms</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Control arm</th><th align="left" valign="top" rowspan="1" colspan="1">Intervention arm</th></tr></thead><tbody><tr><td align="left" colspan="3" rowspan="1">3&#x02010; to 4&#x02010;day training workshop</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Reasons for policy change to mRDT testing before malaria treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">How to perform and interpret a mRDT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">What to do for patients with a negative mRDT result</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">How to treat a child with malaria</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">How to recognise and treat a child with signs of severe illness, and when to refer</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">How to recognise a child with fevers caused by other illnesses, and when to refer</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Role&#x02010;play and communication skills</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" colspan="3" rowspan="1">Supporting interventions for trained CHWs</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Training certificate with Ministry of Health logo</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">ACTs: age&#x02010;appropriate pre&#x02010;packed blister packs with pictorial labelling</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pictorial job aids</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Close support supervision after training &#x02013; for first 6 months only</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bicycle, T&#x02010;shirt, monthly kerosene allowance and soap</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" colspan="3" rowspan="1">Supporting interventions in the community</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Community&#x02010;directed selection of CHWs by popular vote</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Community sensitisation about mRDTs (community meetings, churches, women's groups)</td><td align="left" rowspan="1" colspan="1">&#x02713;</td><td align="left" rowspan="1" colspan="1">&#x02713;</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="tmi12748-sec-0009"><title>Intervention</title><p>Participatory training workshops in malaria case management were held for CHWs in each arm, based on a trainer's manual and accompanying set of pictorial job aids (available from <ext-link ext-link-type="uri" xlink:href="http://www.actconsortium.org/RDThomemanagement">www.actconsortium.org/RDThomemanagement</ext-link>). Training workshops lasted 3 days for CHWs in the control arm and 4 days for CHWs in the mRDT intervention arm. The latter received an additional 1&#x02010;day training to cover the rationale for diagnostic testing in febrile patients, performing an mRDT and interpretation of the test result based on training materials from WHO <xref rid="tmi12748-bib-0012" ref-type="ref">12</xref>. CHWs in the intervention arm were trained to treat children with a mRDT&#x02010;positive test and symptoms of uncomplicated malaria with artemether&#x02013;lumefantrine; and to treat mRDT&#x02010;positive children with danger signs with rectal artesunate as a pre&#x02010;referral treatment, and refer these children to the nearest health unit. CHWs were also trained to refer mRDT&#x02010;negative children if the child either had danger signs or other specific symptoms where examination and treatment at a health facility would be beneficial.</p><p>Community health workers in the control villages were trained to either dispense artemether&#x02013;lumefantrine or rectal artesunate based on presumptive diagnosis of malaria, according to signs and symptoms. The training, support materials and procedures were identical in every respect except for the method of diagnosis to be used. In both arms, CHWs were trained in signs for referral (Box <xref rid="tmi12748-fea-0001" ref-type="boxed-text">1</xref>), completion of treatment records, stock management and preparation of blood slides for reference microscopy. Training encouraged interactive discussion and reflective practice, supported by role&#x02010;play to practice communication skills necessary to obtain clinical history and explain outcome of diagnosis, treatment given and referral advice.</p><boxed-text position="float" content-type="Box" id="tmi12748-fea-0001" orientation="portrait"><label>Box 1</label><caption><title>Referral guidelines for community health workers</title></caption><sec id="tmi12748-sec-0022"><p>
<table-wrap id="nlm-table-wrap-1" xml:lang="en" orientation="portrait" position="anchor"><table frame="above" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><tbody><tr><td align="left" rowspan="1" colspan="1">(a) Danger signs for urgent referral</td><td align="left" rowspan="1" colspan="1">(b) Other signs for referral</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Refer using emergency referral form if child shows any of the following symptoms:</italic>
<list list-type="order" id="tmi12748-list-0001"><list-item><p>Convulsions or fits now or within the past 2 days</p></list-item><list-item><p>Coma/loss of consciousness</p></list-item><list-item><p>Patient is confused or very sleepy; cannot be woken</p></list-item><list-item><p>Extreme weakness &#x02013; unable to stand or sit without support</p></list-item><list-item><p>Very Hot &#x02013; with temperature of 38.5&#x000b0;C or more</p></list-item><list-item><p>Very Cold &#x02013; with temperature of 35.0&#x000b0;C or less</p></list-item><list-item><p>Vomiting everything &#x02013; cannot keep down food or drink</p></list-item><list-item><p>Not able to drink or breastfeed</p></list-item><list-item><p>Severe anaemia &#x02013; very pale palms, fingernails, eyelids</p></list-item><list-item><p>Yellow eyes</p></list-item><list-item><p>Difficulty in breathing</p></list-item><list-item><p>Severe dehydration &#x02013; sunken eyes, sunken fontanelle, skin pinch, coated tongue</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<italic>Refer using ordinary referral form if child shows any of the following symptoms:</italic>
<list list-type="order" id="tmi12748-list-0002"><list-item><p>Fever that has lasted for more than 7 days</p></list-item><list-item><p>Fever with measured temperature of 37&#x000b0;C or more and a <underline underline-style="single">negative</underline> malaria test result</p></list-item><list-item><p>Vomiting <underline underline-style="single">and</underline> diarrhoea</p></list-item><list-item><p>Blood in faeces or blood in urine</p></list-item><list-item><p>Pain when passing urine, or frequent urination</p></list-item><list-item><p>Wound or burns</p></list-item><list-item><p>Skin abscess</p></list-item><list-item><p>Painful swelling or lumps in the skin</p></list-item><list-item><p>Ear infection (runny ear or child pulling at ear)</p></list-item><list-item><p>Sticky or red eyes</p></list-item><list-item><p>Fever in a baby &#x0003c;4 months old</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>If RDT result is positive</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>If RDT result is positive</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Treat child (if older than 2 months) with rectal artesunate suppository prior to referral.</td><td align="left" rowspan="1" colspan="1">Treat child (if older than 4 months) with artemether&#x02013;lumefantine tablets prior to referral.</td></tr></tbody></table></table-wrap>
</p></sec></boxed-text></sec><sec id="tmi12748-sec-0010"><title>Supporting interventions</title><p>Recognising that CHWs may need to broker the change in diagnostic practice with communities, the training included practice in communication skills necessary to explain the rationale for diagnostic testing, result of the mRDT test and treatments given. In addition, community sensitisation on diagnostic testing for malaria was carried out throughout the study area prior to the trial (including communities in both arms). The key messages were that not all fevers are malaria and hence a diagnostic test was advisable before treatment with ACT; and a quick test (mRDT) could test for malaria, and these tests were available from government health facilities and trained CHWs in the intervention villages.</p><p>For the first 6 months of implementation (July&#x02013;December 2010), CHWs in both arms received additional close support supervision by project staff through parish&#x02010;level CHW meetings to assist adoption of the new procedures into everyday practice, to promote accurate and complete record keeping and to give advice on how to handle difficult situations that could affect adherence, for example caretakers insisting on treatment even after a negative RDT result. At the end of the 6 months, supervision was scaled back to periodic contacts when CHWs came to collect their supplies and a monthly allowance for paraffin and soap intended to support good hygiene and work in the evening/night (15 000 Uganda Shilling, approximately 4.50 USD). CHWs were also provided with pictorial job aids, training certificates, bicycles and T&#x02010;shirts at the start of the programme. Although CHWs in Uganda are volunteers, expected to work for free, programmes often provide small &#x02018;refunds&#x02019; or tokens, which are generally expected as compensation.</p></sec><sec id="tmi12748-sec-0011"><title>Evaluation of outcomes</title><p>Data on diagnosis and treatment were recorded prospectively on all children seeking treatment for fever in carbon&#x02010;copy duplicated CHWs' registers, provided for this purpose. The treatment register for CHWs in the control arm was similar to the intervention arm except for data on mRDT result. CHWs in both arms were trained on how to prepare a thick blood film for every child with fever who consulted them, for later microscopy, subject to verbal assent given by the caretaker accompanying the child. Treatment decisions made by CHWs were validated by light microscopy on the reference blood slide collected at the time of consultation, to compare appropriate targeting of ACTs between arms over a 12&#x02010;month period (January&#x02013;December 2011). The primary endpoint was the proportion of febrile children with malaria receiving appropriately targeted treatment with a first&#x02010;line antimalarial, a composite outcome defined as: children with microscopically&#x02010;confirmed presence of parasites in a peripheral blood smear (slide positive) who received either artemether&#x02013;lumefantrine or rectal artesunate, and febrile children with no malaria parasites (slide negative) who did not receive either of these two artemisin&#x02010;based treatments (denominator: all consultations for fever or history of fever). The other co&#x02010;primary outcome was prompt effective treatment defined as the proportion of febrile children who received appropriately targeted ACT treatment from a CHW within 24 h of onset of malaria symptoms, while the secondary outcome was over&#x02010;prescription defined as the proportion of children not parasite&#x02010;positive (slide negative) who received inappropriate ACT treatment from CHW (denominator: all children with a negative research slide).</p></sec><sec id="tmi12748-sec-0012"><title>Sample size estimation</title><p>Based on an observed prevalence of malaria of 50% and inter&#x02010;cluster variation <italic>k</italic> = 0.35 in the moderate&#x02010;to&#x02010;high transmission area during the period of close support supervision, a minimum sample size of 6 patients per cluster (180 patients per arm) was required to demonstrate a 50% increase in appropriately targeted treatment with use of mRDTs from 50% to 75%, with 90% power at the 5% significance level, in a cluster&#x02010;randomised trial with 30 clusters per arm. The equivalent sample size in the low transmission area, with 30% malaria prevalence, 32 clusters per arm and inter&#x02010;cluster variation <italic>k</italic> = 0.45, to demonstrate an increase from 30% to 65% was 2 patients per cluster (128 patients per arm). Taking into account the lower proportion of cases seeking treatment within 24 h of onset of symptoms (89% and 83% in each site), sample size requirements to detect a comparable increase in prompt appropriately targeted treatment were 9 patients and 3 patients per cluster (270 and 192 per arm), in the high&#x02010;to&#x02010;moderate and low transmission areas respectively.</p></sec><sec id="tmi12748-sec-0013"><title>Laboratory methods</title><p>A finger&#x02010;prick blood sample was collected by the CHW at the time of consultation, a thick blood film for microscopy prepared, and mRDT (First Response<sup>&#x000ae;</sup> Ag. P. falciparum (HRP2) Card test, <ext-link ext-link-type="uri" xlink:href="http://www.PremierMedCorp.com">www.PremierMedCorp.com</ext-link>; intervention arm only) performed. The mRDTs passed independent quality&#x02010;assurance batch testing by WHO&#x02010;FIND, Institut Pasteur, Cambodia. Thick blood smears were haemolysed and stained with 10% Giemsa for 10 min and examined under light microscopy with oil immersion objective lens (&#x000d7;100). Asexual parasites were counted against 200 white blood cells and parasite densities calculated assuming a standard white blood cell count of 8000/<italic>&#x003bc;</italic>l blood. A blood smear was declared negative if no parasites were detected in 100 high power fields. Reference slides included in the analysis of the primary endpoint were subjected to two independent readings by light microscopy. The second reading was performed by experienced technicians at Vector Control Division, Ministry of Health in Kampala, blinded to initial results. Any discrepant results between the first and second readings were resolved by a third technician blinded to all previous results. As the number of consultations in Bwambara (moderate&#x02010;to&#x02010;high transmission area) exceeded the sample size requirements, a subsample of blood slides was randomly selected for analysis of the primary endpoint. To reflect seasonal variation in the prevalence of malaria, two slides were randomly sampled per month from each village during the main evaluation period from January to December 2011 for double reading (a total of 24 slides per cluster). Malaria was less common in Nyakashenyi, with fewer consultations, and thus, all available slides were re&#x02010;examined by expert microscopy.</p></sec><sec id="tmi12748-sec-0014"><title>Statistical methods</title><p>Data were analysed as intention&#x02010;to&#x02010;treat, with analysis conducted separately for each transmission setting. Due to the withdrawal of some clusters from the study after randomisation in the moderate&#x02010;to&#x02010;high transmission setting (Figure <xref rid="tmi12748-fig-0002" ref-type="fig">2</xref>), data were analysed as modified&#x02010;intention&#x02010;to&#x02010;treat. To account for cluster&#x02010;randomised design, a random effects logistic regression model was used to estimate intervention effects and 95% confidence intervals; a quadrature check performed to confirm model was a reliable fit to the data, and likelihood ratio test used to assess statistical significance <xref rid="tmi12748-bib-0013" ref-type="ref">13</xref>. The analytical plan was approved by an independent data safety and monitoring board, prior to analysis. Data were double&#x02010;entered and verified using Microsoft Access 2007 (Microsoft Inc., Redmond, USA) and analysed using STATA version 12 (STATA Corporation, College Station, Texas, USA).</p><fig fig-type="Figure" xml:lang="en" id="tmi12748-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Trial profile, moderate&#x02010;to&#x02010;high transmission area. <sup>1</sup>After training, <styled-content style="fixed-case">CHW</styled-content>s in villages located close to the border of the study area started to receive febrile children from outside the study district; these villages were subsequently withdrawn from the trial.</p></caption><graphic id="nlm-graphic-3" xlink:href="TMI-21-1157-g002"/></fig></sec><sec id="tmi12748-sec-0015"><title>Ethical approval</title><p>This study was approved by the Uganda National Council for Science and Technology and the London School of Hygiene &#x00026; Tropical Medicine Ethics Committee. Patients refusing an mRDT test received presumptive treatment. The study was registered with <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link>. Identifier NCT01048801 on 13 January 2010.</p></sec></sec><sec id="tmi12748-sec-0016"><title>Results</title><p>To account for seasonal variations in malaria risk, data were analysed for a 12&#x02010;month period of routine implementation (January&#x02013;December 2011), after the training and 6&#x02010;month period of close support supervision had ended. During 2011, a total of 13 035 children were seen by CHWs in 63 villages in Bwambara subcounty (the moderate&#x02010;to&#x02010;high malaria transmission area), with 5715 children seen by CHWs in the mRDT intervention arm and 7320 in the control arm (Figure <xref rid="tmi12748-fig-0002" ref-type="fig">2</xref>). In Nyakashenyi subcounty (the low transmission area), a total of 2676 children were registered by CHWs in 64 villages during the same period: 908 and 1768 in mRDT and presumptive arm, respectively (Figure <xref rid="tmi12748-fig-0003" ref-type="fig">3</xref>). Most patients were willing to provide a blood sample, in all study arms, with few refusals.</p><fig fig-type="Figure" xml:lang="en" id="tmi12748-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Trial profile, low transmission area.</p></caption><graphic id="nlm-graphic-5" xlink:href="TMI-21-1157-g003"/></fig><p>In both transmission settings, the number of consultations in the control arm usually exceeded those in the mRDT arm, although the seasonal pattern was similar across arms (Figure <xref rid="tmi12748-fig-0004" ref-type="fig">4</xref>). In Bwambara subcounty, changes in mRDT positivity mirrored changes in blood slide positivity. In Nyakashenyi subcounty, slide positivity was generally &#x0003c;10%, but increased to 35.7% in August 2011; mRDT positivity reached a peak of 9% in the same month.</p><fig fig-type="Figure" xml:lang="en" id="tmi12748-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Consultations for fever, malaria blood slide and rapid diagnostic test positivity by month in two areas of contrasting malaria transmission intensity in south&#x02010;western Uganda: January&#x02013;December 2011. (a) Bwambara subcounty, moderate&#x02010;to&#x02010;high transmission setting. (b) Nyakishenyi subcounty, low transmission setting.</p></caption><graphic id="nlm-graphic-7" xlink:href="TMI-21-1157-g004"/></fig><sec id="tmi12748-sec-0017"><title>Effect of intervention on appropriately targeted treatment: moderate&#x02010;to&#x02010;high transmission setting</title><p>Of the 12 914 blood slides collected by CHWs in Bwambara subcounty, 1543 were sampled for validation of the treatment decision by expert microscopy (Figure <xref rid="tmi12748-fig-0002" ref-type="fig">2</xref>). Appropriately targeted treatment was evaluated in patients for whom data on two or more independent slide readings were available: 699 patients in the control arm and 656 patients in the mRDT intervention arm, comprising 87.0% and 88.6% of the slides sampled in each arm, respectively. CHW and patient characteristics were generally similar between the two arms (Table <xref rid="tmi12748-tbl-0002" ref-type="table-wrap">2</xref>). While over 80% of patients had sought treatment within 24 h of onset of symptoms, there was greater delay in the mRDT intervention villages than controls. Slide positivity was also higher in the mRDT intervention arm, 37.8% <italic>vs</italic>. 30.2% control (Table <xref rid="tmi12748-tbl-0003" ref-type="table-wrap">3</xref>), with 37.6% of children in the intervention arm testing mRDT positive. The sensitivity and specificity of mRDT result against expert microscopy were 72.1% and 83.3%, respectively, with a positive predictive value (PPV) of 72.4% and negative predictive value (NPV) of 83.1% in this area of moderate&#x02010;to&#x02010;high transmission (Table <xref rid="tmi12748-tbl-0005" ref-type="table-wrap">5</xref>).</p><table-wrap id="tmi12748-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Characteristics of clusters and community health workers in the intervention and control arms</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="3" valign="top" colspan="1"/><th align="left" rowspan="3" valign="top" colspan="1"/><th align="char" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Moderate&#x02010;to&#x02010;high transmission</th><th align="char" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Low transmission</th></tr><tr><th align="char" valign="top" rowspan="1" colspan="1">Control arm</th><th align="char" valign="top" rowspan="1" colspan="1">Intervention arm</th><th align="char" valign="top" rowspan="1" colspan="1">Control arm</th><th align="char" valign="top" rowspan="1" colspan="1">Intervention arm</th></tr><tr style="border-bottom:solid 1px #000000"><th align="char" valign="top" rowspan="1" colspan="1">Frequency (%)</th><th align="char" valign="top" rowspan="1" colspan="1">Frequency (%)</th><th align="char" valign="top" rowspan="1" colspan="1">Frequency (%)</th><th align="char" valign="top" rowspan="1" colspan="1">Frequency (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of participating villages</td><td align="left" rowspan="1" colspan="1"/><td align="char" char=" " rowspan="1" colspan="1">31</td><td align="char" char=" " rowspan="1" colspan="1">32</td><td align="char" char=" " rowspan="1" colspan="1">32</td><td align="char" char=" " rowspan="1" colspan="1">32</td></tr><tr><td align="left" rowspan="1" colspan="1">Total number of CHWs</td><td align="left" rowspan="1" colspan="1"/><td align="char" char=" " rowspan="1" colspan="1">90</td><td align="char" char=" " rowspan="1" colspan="1">90</td><td align="char" char=" " rowspan="1" colspan="1">96</td><td align="char" char=" " rowspan="1" colspan="1">96</td></tr><tr><td align="left" colspan="6" rowspan="1">CHWs characteristics<xref ref-type="fn" rid="tmi12748-note-0012">a</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Total CHWs interviewed</td><td align="left" rowspan="1" colspan="1"/><td align="char" char=" " rowspan="1" colspan="1">74</td><td align="char" char=" " rowspan="1" colspan="1">81</td><td align="char" char=" " rowspan="1" colspan="1">21</td><td align="char" char=" " rowspan="1" colspan="1">17</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age in years</td><td align="left" rowspan="1" colspan="1">Median</td><td align="char" char=" " rowspan="1" colspan="1">39</td><td align="char" char=" " rowspan="1" colspan="1">40</td><td align="char" char=" " rowspan="1" colspan="1">41</td><td align="char" char=" " rowspan="1" colspan="1">40</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">Male</td><td align="char" char=" " rowspan="1" colspan="1">24 (32.4)</td><td align="char" char=" " rowspan="1" colspan="1">26 (32.1)</td><td align="char" char=" " rowspan="1" colspan="1">6 (28.6)</td><td align="char" char=" " rowspan="1" colspan="1">2 (11.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="char" char=" " rowspan="1" colspan="1">50 (67.6)</td><td align="char" char=" " rowspan="1" colspan="1">55 (67.9)</td><td align="char" char=" " rowspan="1" colspan="1">15 (71.4)</td><td align="char" char=" " rowspan="1" colspan="1">15 (88.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="4" colspan="1">Highest level of school attendance</td><td align="left" rowspan="1" colspan="1">Never</td><td align="char" char=" " rowspan="1" colspan="1">1 (1.6)</td><td align="char" char=" " rowspan="1" colspan="1">6 (6.4)</td><td align="char" char=" " rowspan="1" colspan="1">0 (0)</td><td align="char" char=" " rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Primary</td><td align="char" char=" " rowspan="1" colspan="1">40 (64.5)</td><td align="char" char=" " rowspan="1" colspan="1">46 (59.0)</td><td align="char" char=" " rowspan="1" colspan="1">11 (52.4)</td><td align="char" char=" " rowspan="1" colspan="1">11 (64.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Secondary</td><td align="char" char=" " rowspan="1" colspan="1">20 (33.9)</td><td align="char" char=" " rowspan="1" colspan="1">21 (33.3)</td><td align="char" char=" " rowspan="1" colspan="1">10 (47.6)</td><td align="char" char=" " rowspan="1" colspan="1">6 (35.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tertiary</td><td align="char" char=" " rowspan="1" colspan="1">0 (0)</td><td align="char" char=" " rowspan="1" colspan="1">1 (1.3)</td><td align="char" char=" " rowspan="1" colspan="1">0 (0)</td><td align="char" char=" " rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" colspan="1">CHW before</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="char" char=" " rowspan="1" colspan="1">47 (65.3)</td><td align="char" char=" " rowspan="1" colspan="1">39 (52.7)</td><td align="char" char=" " rowspan="1" colspan="1">14 (66.7)</td><td align="char" char=" " rowspan="1" colspan="1">7 (41.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="char" char=" " rowspan="1" colspan="1">25 (34.7)</td><td align="char" char=" " rowspan="1" colspan="1">35 (47.3)</td><td align="char" char=" " rowspan="1" colspan="1">7 (33.3)</td><td align="char" char=" " rowspan="1" colspan="1">10 (58.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" colspan="1">Involvement in health activities before</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="char" char=" " rowspan="1" colspan="1">21 (30.0)</td><td align="char" char=" " rowspan="1" colspan="1">31 (45.6)</td><td align="char" char=" " rowspan="1" colspan="1">5 (26.3)</td><td align="char" char=" " rowspan="1" colspan="1">5 (31.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="char" char=" " rowspan="1" colspan="1">49 (68.1)</td><td align="char" char=" " rowspan="1" colspan="1">37 (50.0)</td><td align="char" char=" " rowspan="1" colspan="1">14 (66.7)</td><td align="char" char=" " rowspan="1" colspan="1">11 (64.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Elevation (metres above sea level)</td><td align="left" rowspan="1" colspan="1">Mean (SD)</td><td align="char" char=" " rowspan="1" colspan="1">1131.21 (184.9)</td><td align="char" char=" " rowspan="1" colspan="1">1086.0 (53.7)</td><td align="char" char=" " rowspan="1" colspan="1">1829.8 (110.0)</td><td align="char" char=" " rowspan="1" colspan="1">1839.0 (120.9)</td></tr><tr><td align="left" colspan="6" rowspan="1">Patient characteristics<xref ref-type="fn" rid="tmi12748-note-0013">b</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Total number of children seen by CHW</td><td align="left" rowspan="1" colspan="1"/><td align="char" char=" " rowspan="1" colspan="1">699</td><td align="char" char=" " rowspan="1" colspan="1">656</td><td align="char" char=" " rowspan="1" colspan="1">817</td><td align="char" char=" " rowspan="1" colspan="1">403</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age in years</td><td align="left" rowspan="1" colspan="1">Mean (SD)</td><td align="char" char=" " rowspan="1" colspan="1">2.8 (1.5)</td><td align="char" char=" " rowspan="1" colspan="1">2.6 (1.4)</td><td align="char" char=" " rowspan="1" colspan="1">2.6 (1.4)</td><td align="char" char=" " rowspan="1" colspan="1">2.4 (1.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">Male</td><td align="char" char=" " rowspan="1" colspan="1">359 (51.7</td><td align="char" char=" " rowspan="1" colspan="1">335 (51.1)</td><td align="char" char=" " rowspan="1" colspan="1">434 (53.2)</td><td align="char" char=" " rowspan="1" colspan="1">198 (49.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="char" char=" " rowspan="1" colspan="1">336 (48.3)</td><td align="char" char=" " rowspan="1" colspan="1">320 (48.9)</td><td align="char" char=" " rowspan="1" colspan="1">382 (46.8)</td><td align="char" char=" " rowspan="1" colspan="1">204 (50.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" colspan="1">Slept under a mosquito net the previous night</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="char" char=" " rowspan="1" colspan="1">639 (92.7)</td><td align="char" char=" " rowspan="1" colspan="1">567 (87.4)</td><td align="char" char=" " rowspan="1" colspan="1">737 (91.1)</td><td align="char" char=" " rowspan="1" colspan="1">351 (87.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="char" char=" " rowspan="1" colspan="1">50 (7.3)</td><td align="char" char=" " rowspan="1" colspan="1">82 (12.6)</td><td align="char" char=" " rowspan="1" colspan="1">72 (8.9)</td><td align="char" char=" " rowspan="1" colspan="1">49 (12.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" colspan="1">Resident in same village as CHW</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="char" char=" " rowspan="1" colspan="1">644 (92.5)</td><td align="char" char=" " rowspan="1" colspan="1">599 (91.6)</td><td align="char" char=" " rowspan="1" colspan="1">732 (89.8)</td><td align="char" char=" " rowspan="1" colspan="1">331 (82.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="char" char=" " rowspan="1" colspan="1">52 (7.5)</td><td align="char" char=" " rowspan="1" colspan="1">55 (8.4)</td><td align="char" char=" " rowspan="1" colspan="1">83 (10.2)</td><td align="char" char=" " rowspan="1" colspan="1">70 (17.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" colspan="1">Time of presentation to CHW after of onset of symptoms</td><td align="left" rowspan="1" colspan="1">Within 24 h</td><td align="char" char=" " rowspan="1" colspan="1">641 (93.4)</td><td align="char" char=" " rowspan="1" colspan="1">544 (84.6)</td><td align="char" char=" " rowspan="1" colspan="1">698 (88.8)</td><td align="char" char=" " rowspan="1" colspan="1">319 (80.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">More than 24 h</td><td align="char" char=" " rowspan="1" colspan="1">45 (6.6)</td><td align="char" char=" " rowspan="1" colspan="1">99 (15.4)</td><td align="char" char=" " rowspan="1" colspan="1">88 (11.2)</td><td align="char" char=" " rowspan="1" colspan="1">79 (19.8)</td></tr></tbody></table><table-wrap-foot><fn id="tmi12748-note-0012"><label>a</label><p>Data missing in moderate&#x02010;to&#x02010;high transmission setting, for highest level of school attendance: 21 (13 control, 8 intervention); previous CHW status: 9 (2 control arm, 7 intervention); involvement in health activities before: 17 (4 control, 13 intervention). Data missing in low transmission setting, for involvement in health activities before: 3 (2 control, 1 intervention).</p></fn><fn id="tmi12748-note-0013"><label>b</label><p>Data missing in moderate&#x02010;to&#x02010;high transmission setting, for age: 4 (2 control, 2 intervention); sex: 5 (4 control, 1 intervention); net use: 17 (10 control, 7 intervention); resident in same village 5 (3 control, 2 intervention); onset of symptoms: 26 (13 control, 13 intervention). Data missing in low transmission setting, for age: 14 (5 control, 9 intervention); sex: 2 (1 control, 1 intervention); net use: 11 (8 control, 3 intervention); resident in same village:4 (2 control, 2 intervention); onset of symptoms: 36 (31 control, 5 intervention).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="tmi12748-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Diagnosis and treatment of malaria by CHWs in Bwambara subcounty, January&#x02013;December 2011: moderate&#x02010;to&#x02010;high transmission setting</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="top" colspan="1">Diagnosis and treatment</th><th align="char" valign="top" rowspan="1" colspan="1">Control arm 31 clusters</th><th align="char" char=" " valign="top" rowspan="1" colspan="1">Intervention arm 32 clusters</th><th align="char" char=" " valign="top" rowspan="1" colspan="1"/><th align="char" valign="top" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000"><th align="char" valign="top" rowspan="1" colspan="1">Frequency (%)</th><th align="char" char=" " valign="top" rowspan="1" colspan="1">Frequency (%)</th><th align="char" char=" " valign="top" rowspan="1" colspan="1"/><th align="char" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Patients with complete data for primary endpoint</td><td align="char" char=" " rowspan="1" colspan="1">699</td><td align="char" char=" " rowspan="1" colspan="1">656</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide positive</td><td align="char" char=" " rowspan="1" colspan="1">211 (30.2)</td><td align="char" char=" " rowspan="1" colspan="1">248 (37.8)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">mRDT positive<xref ref-type="fn" rid="tmi12748-note-0001">a</xref>
</td><td align="char" char=" " rowspan="1" colspan="1">n/a</td><td align="char" char=" " rowspan="1" colspan="1">243 (37.6)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Malaria treatment prescribed</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Artemether&#x02010;lumefantrine tablets (AL)</td><td align="char" char=" " rowspan="1" colspan="1">692 (99.0)</td><td align="char" char=" " rowspan="1" colspan="1">244 (37.2)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rectal artesunate suppository</td><td align="char" char=" " rowspan="1" colspan="1">3 (0.4)</td><td align="char" char=" " rowspan="1" colspan="1">2 (0.3)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Neither AL nor rectal artesunate</td><td align="char" char=" " rowspan="1" colspan="1">4 (0.6)</td><td align="char" char=" " rowspan="1" colspan="1">410 (62.5)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Malaria treatment by infection status</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide negative, received no ACT<xref ref-type="fn" rid="tmi12748-note-0002">b</xref>
</td><td align="char" char=" " rowspan="1" colspan="1">4 (0.8)</td><td align="char" char=" " rowspan="1" colspan="1">341 (83.4)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide negative, received ACT</td><td align="char" char=" " rowspan="1" colspan="1">484 (99.2)</td><td align="char" char=" " rowspan="1" colspan="1">67 (16.4)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide positive, received ACT</td><td align="char" char=" " rowspan="1" colspan="1">211 (100.0)</td><td align="char" char=" " rowspan="1" colspan="1">179 (72.2)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide positive, received no ACT</td><td align="char" char=" " rowspan="1" colspan="1">0 (0.0)</td><td align="char" char=" " rowspan="1" colspan="1">69 (27.8)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Trial endpoints</bold>
</td><td align="char" char=" " rowspan="1" colspan="1">
<italic><bold>n</bold></italic>
<bold>(%)</bold>
</td><td align="char" char=" " rowspan="1" colspan="1">
<italic><bold>n</bold></italic>
<bold>(%)</bold>
</td><td align="char" char=" " rowspan="1" colspan="1">
<bold>Odds ratio (95% CI)</bold>
</td><td align="char" rowspan="1" colspan="1">
<italic><bold>P</bold></italic>
<bold>&#x02010;value</bold>
</td></tr><tr><td align="left" colspan="5" rowspan="1">Over&#x02010;prescription</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Proportion of blood slide negative patients receiving ACT<xref ref-type="fn" rid="tmi12748-note-0002">b</xref>
</td><td align="char" char=" " rowspan="1" colspan="1">484 (99.2)</td><td align="char" char=" " rowspan="1" colspan="1">67 (16.4)</td><td align="char" char=" " rowspan="1" colspan="1">0.0013 (0.0004&#x02013;0.0039)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">Appropriately targeted treatment</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Proportion of febrile patients receiving appropriately targeted malaria treatment with ACT</td><td align="char" char=" " rowspan="1" colspan="1">215 (30.8)</td><td align="char" char=" " rowspan="1" colspan="1">520 (79.3)</td><td align="char" char=" " rowspan="1" colspan="1">9.71 (6.83&#x02013;13.80)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">Prompt and appropriately targeted treatment</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Proportion of febrile patients receiving appropriately targeted treatment within 24 hours of onset of symptoms<xref ref-type="fn" rid="tmi12748-note-0003">c</xref>
</td><td align="char" char=" " rowspan="1" colspan="1">195 (28.1)</td><td align="char" char=" " rowspan="1" colspan="1">433 (67.0)</td><td align="char" char=" " rowspan="1" colspan="1">5.92 (4.15&#x02013;8.45)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tmi12748-note-0001"><label>a</label><p>Ten patients missing RDT results.</p></fn><fn id="tmi12748-note-0002"><label>b</label><p>ACT defined as receiving either artemether&#x02010;lumefantrine or rectal artesunate.</p></fn><fn id="tmi12748-note-0003"><label>c</label><p>Fifteen missing data on time of treatment (five control, 10 intervention).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Among febrile children seen by CHWs in the mRDT intervention arm, 37.5% were treated with either artemether&#x02013;lumefantrine or rectal artesunate (hereafter referred to collectively as ACT) compared with almost 100% of children seen by CHWs using presumptive diagnosis (Table <xref rid="tmi12748-tbl-0003" ref-type="table-wrap">3</xref>). Only 16.4% of slide&#x02010;negative children in the mRDT intervention arm received an ACT, a significant reduction in over&#x02010;prescription compared with the control arm, <italic>P</italic> &#x0003c; 0.001. Sixty&#x02010;nine of the patients in the mRDT intervention arm who did not receive ACT treatment were slide positive, of whom 35 (51%) had parasite densities &#x02264;200 parasites per <italic>&#x003bc;</italic>l (Figure <xref rid="tmi12748-fig-0005" ref-type="fig">5</xref>a). Use of mRDTs was thus associated with a significant overall improvement in the targeting of ACT treatments, such that in this area of moderate&#x02010;to&#x02010;high transmission, 79.3% of children in the mRDT arm received appropriately targeted treatment compared with 30.8% in the control arm (odds ratio 9.71, 95% CI 6.83&#x02013;13.80; <italic>P</italic> &#x0003c; 0.001). Despite greater delay in seeking treatment in the mRDT arm, the proportion of children who received appropriately targeted treatment within 24 h was also significantly higher in the intervention arm (67.0% <italic>vs</italic>. 28.1%; odds ratio 5.92, 95% CI 4.15&#x02013;8.45; <italic>P</italic> &#x0003c; 0.001).</p><fig fig-type="Figure" xml:lang="en" id="tmi12748-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Rapid diagnostic test results performed and read by community health workers in relation to parasite density measured by expert light microscopy (Data are shown for children with parasites detected in a thick blood film). (a) Moderate&#x02010;to&#x02010;high transmission area. (b) Low transmission area.</p></caption><graphic id="nlm-graphic-9" xlink:href="TMI-21-1157-g005"/></fig></sec><sec id="tmi12748-sec-0018"><title>Effect of intervention on appropriately targeted treatment: low transmission setting</title><p>A total of 2543 blood slides were collected by CHWs in Nyakashenyi subcounty, of which two or more independent slide readings were available for 49.0% and 47.1% of slides in the control and mRDT arm, respectively (Figure <xref rid="tmi12748-fig-0003" ref-type="fig">3</xref>). Patient records missing treatment data were few. Appropriately targeted treatment was thus evaluated in the 817 and 403 patients with complete data in the control and mRDT intervention arms, comprising 46.2% and 44.4% of consultations in each arm, respectively. Reasons for data loss included poor quality of the slides prepared by CHWs and missing data on validation microscopy. CHW and patient characteristics were similar between the two arms, although, as in the high transmission area, there was slightly greater treatment delay in mRDT intervention villages than controls; 80.2% <italic>vs</italic>. 88.8%, respectively, had sought treatment within 24 h of onset of symptoms (Table <xref rid="tmi12748-tbl-0002" ref-type="table-wrap">2</xref>). Slide positivity was 5.7% overall, and similar in the two arms (Table <xref rid="tmi12748-tbl-0004" ref-type="table-wrap">4</xref>), with 3.0% of children in the intervention arm reported to be mRDT positive. The sensitivity of mRDT result against microscopy was low (20.8%), and specificity was 98.1% (Table <xref rid="tmi12748-tbl-0005" ref-type="table-wrap">5</xref>). PPV in this low transmission setting was 41.7%, and NPV, 95.1%.</p><table-wrap id="tmi12748-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>Diagnosis and treatment of malaria by CHWs in Nyakishenyi subcounty, January&#x02013;December 2011: low transmission setting</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="top" colspan="1">Diagnosis and treatment</th><th align="char" char=" " valign="top" rowspan="1" colspan="1">Control arm 32 clusters</th><th align="char" char=" " valign="top" rowspan="1" colspan="1">Intervention arm 32 clusters</th><th align="char" char=" " valign="top" rowspan="1" colspan="1"/><th align="char" valign="top" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000"><th align="char" char=" " valign="top" rowspan="1" colspan="1">Frequency (%)</th><th align="char" char=" " valign="top" rowspan="1" colspan="1">Frequency (%)</th><th align="char" char=" " valign="top" rowspan="1" colspan="1"/><th align="char" valign="top" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Patients with complete data for primary endpoint</td><td align="char" char=" " rowspan="1" colspan="1">817</td><td align="char" char=" " rowspan="1" colspan="1">403</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide positive</td><td align="char" char=" " rowspan="1" colspan="1">46 (5.6)</td><td align="char" char=" " rowspan="1" colspan="1">24 (6.0)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">mRDT Positive<xref ref-type="fn" rid="tmi12748-note-0004">a</xref>
</td><td align="char" char=" " rowspan="1" colspan="1">n/a</td><td align="char" char=" " rowspan="1" colspan="1">12 (3.0)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Malaria treatment prescribed</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Artemether&#x02010;lumefantrine tablets (AL)</td><td align="char" char=" " rowspan="1" colspan="1">773 (94.6)</td><td align="char" char=" " rowspan="1" colspan="1">22 (5.5)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rectal artesunate suppository</td><td align="char" char=" " rowspan="1" colspan="1">18 (2.2)</td><td align="char" char=" " rowspan="1" colspan="1">6 (1.5)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Neither AL nor rectal artesunate</td><td align="char" char=" " rowspan="1" colspan="1">26 (3.2)</td><td align="char" char=" " rowspan="1" colspan="1">375 (93.1)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Malaria treatment by infection status</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide negative, received no ACT<xref ref-type="fn" rid="tmi12748-note-0005">b</xref>
</td><td align="char" char=" " rowspan="1" colspan="1">22 (2.9)</td><td align="char" char=" " rowspan="1" colspan="1">357 (94.2)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide negative, received ACT</td><td align="char" char=" " rowspan="1" colspan="1">749 (97.2)</td><td align="char" char=" " rowspan="1" colspan="1">22 (5.8)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide positive, received ACT</td><td align="char" char=" " rowspan="1" colspan="1">42 (91.3)</td><td align="char" char=" " rowspan="1" colspan="1">6 (25.0)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Blood slide positive, received no ACT</td><td align="char" char=" " rowspan="1" colspan="1">4 (8.7)</td><td align="char" char=" " rowspan="1" colspan="1">18 (75.0)</td><td align="char" char=" " rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Trial endpoints</bold>
</td><td align="char" char=" " rowspan="1" colspan="1">
<italic><bold>n</bold></italic>
<bold>(%)</bold>
</td><td align="char" char=" " rowspan="1" colspan="1">
<italic><bold>n</bold></italic>
<bold>(%)</bold>
</td><td align="char" char=" " rowspan="1" colspan="1">
<bold>Odds ratio (95% CI)</bold>
</td><td align="char" rowspan="1" colspan="1">
<italic><bold>P</bold></italic>
<bold>&#x02010;value</bold>
</td></tr><tr><td align="left" colspan="5" rowspan="1">Over&#x02010;prescription</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Proportion of blood slide negative patients receiving ACT</td><td align="char" char=" " rowspan="1" colspan="1">749 (97.2)</td><td align="char" char=" " rowspan="1" colspan="1">22 (5.8)</td><td align="char" char=" " rowspan="1" colspan="1">0.00022 (0.00004&#x02013;0.00125)</td><td align="char" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" colspan="5" rowspan="1">Appropriately targeted treatment</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Proportion of febrile patients receiving appropriately targeted malaria treatment with ACT</td><td align="char" char=" " rowspan="1" colspan="1">64 (7.8)</td><td align="char" char=" " rowspan="1" colspan="1">363 (90.1)</td><td align="char" char=" " rowspan="1" colspan="1">162.9 (83.0 &#x02013; 319.6)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" colspan="5" rowspan="1">Prompt and appropriately targeted treatment</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Proportion of febrile patients receiving appropriately targeted treatment within 24 hours of onset of symptoms<xref ref-type="fn" rid="tmi12748-note-0006">c</xref>
</td><td align="char" char=" " rowspan="1" colspan="1">49 (6.0)</td><td align="char" char=" " rowspan="1" colspan="1">287 (72.1)</td><td align="char" char=" " rowspan="1" colspan="1">40.3 (28.1 &#x02010; 57.9)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tmi12748-note-0004"><label>a</label><p>One patient missing mRDT result.</p></fn><fn id="tmi12748-note-0005"><label>b</label><p>ACT defined as receiving either artemether&#x02010;lumefantrine or rectal artesunate.</p></fn><fn id="tmi12748-note-0006"><label>c</label><p>Nine missing data on time of treatment (four control, five intervention).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="tmi12748-tbl-0005" xml:lang="en" orientation="portrait" position="float"><label>Table 5</label><caption><p>Sensitivity and specificity of malaria rapid diagnostic tests (mRDTs) performed by community health workers in two areas of contrasting transmission intensity</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="3" valign="top" colspan="1">Result reported by CHW<xref ref-type="fn" rid="tmi12748-note-0008">a</xref>
</th><th align="char" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Moderate&#x02010;to&#x02010;high transmission setting</th><th align="char" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Low transmission setting</th></tr><tr style="border-bottom:solid 1px #000000"><th align="char" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Expert microscopy<xref ref-type="fn" rid="tmi12748-note-0009">b</xref>
</th><th align="char" rowspan="2" style="border-bottom:solid 1px #000000" valign="top" colspan="1">Predictive value of mRDT, %</th><th align="char" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Expert microscopy<xref ref-type="fn" rid="tmi12748-note-0009">b</xref>
</th><th align="char" rowspan="2" style="border-bottom:solid 1px #000000" valign="top" colspan="1">Predictive value of mRDT, %</th></tr><tr style="border-bottom:solid 1px #000000"><th align="char" valign="top" rowspan="1" colspan="1">Positive (%)</th><th align="char" valign="top" rowspan="1" colspan="1">Negative (%)</th><th align="char" valign="top" rowspan="1" colspan="1">Positive (%)</th><th align="char" valign="top" rowspan="1" colspan="1">Negative (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">mRDT positive</td><td align="char" char=" " rowspan="1" colspan="1">176 (72.1)</td><td align="char" char=" " rowspan="1" colspan="1">67 (16.7)</td><td align="char" char="." rowspan="1" colspan="1">72.4</td><td align="char" char=" " rowspan="1" colspan="1">5 (20.8)</td><td align="char" char=" " rowspan="1" colspan="1">7 (1.9)</td><td align="char" char="." rowspan="1" colspan="1">41.7</td></tr><tr><td align="left" rowspan="1" colspan="1">mRDT negative</td><td align="char" char=" " rowspan="1" colspan="1">68 (27.9)</td><td align="char" char=" " rowspan="1" colspan="1">335 (88.3)</td><td align="char" char="." rowspan="1" colspan="1">83.1</td><td align="char" char=" " rowspan="1" colspan="1">19 (79.2)</td><td align="char" char=" " rowspan="1" colspan="1">371 (98.1)</td><td align="char" char="." rowspan="1" colspan="1">95.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Total samples examined</td><td align="char" char=" " rowspan="1" colspan="1">244</td><td align="char" char=" " rowspan="1" colspan="1">402</td><td align="char" rowspan="1" colspan="1"/><td align="char" char=" " rowspan="1" colspan="1">24</td><td align="char" char=" " rowspan="1" colspan="1">378</td><td align="char" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tmi12748-note-0008"><label>a</label><p>Missing data on RDT result: 10 in high transmission setting; 1 in low transmission setting.</p></fn><fn id="tmi12748-note-0009"><label>b</label><p>Result of blood slides double&#x02010;read by two independent microscopists, with discrepant findings resolved by a third independent reader; all blind to RDT result.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>When compared with malaria status by microscopy, 5.8% of slide&#x02010;negative children in the mRDT intervention arm received an ACT, a significant reduction in overprescription compared with control arm, <italic>P</italic> = 0.002 (Table <xref rid="tmi12748-tbl-0004" ref-type="table-wrap">4</xref>). However, of the 24 patients who were slide positive, only 6 had received ACT treatment; 17 of the 18 that were untreated had parasite densities &#x02264;200 parasites per <italic>&#x003bc;</italic>l (Figure <xref rid="tmi12748-fig-0005" ref-type="fig">5</xref>b). Overall, use of mRDTs was associated with a dramatic improvement in the targeting of ACT treatments; 94.2% of children in the mRDT intervention arm received appropriately targeted treatment compared with 25.0% on the control arm (odds ratio 162.9, 95% CI 83.0&#x02013;319.6; <italic>P</italic> &#x0003c; 0.001). The proportion of children who received appropriately targeted treatment within 24 h was also significantly higher in the intervention arm (72.1% <italic>vs</italic>. 6.0%, <italic>P</italic> &#x0003c; 0.001).</p></sec></sec><sec id="tmi12748-sec-0019"><title>Discussion</title><p>This study confirms that use of mRDTs by CHWs can reduce the number of ACTs used, as documented in previous studies <xref rid="tmi12748-bib-0010" ref-type="ref">10</xref>, <xref rid="tmi12748-bib-0014" ref-type="ref">14</xref>, <xref rid="tmi12748-bib-0015" ref-type="ref">15</xref>, and additionally demonstrates that mRDTs can substantially improve the targeting of ACT treatment to children with malaria in community&#x02010;based treatment programmes. With use of mRDT&#x02010;based diagnosis, the proportion of children receiving appropriately targeted ACT treatment from CHWs (consistent with their true malaria infection status as determined by later expert microscopy) exceeded 80% in both transmission settings; a significant increase over presumptive treatment (<italic>P</italic> &#x0003c; 0.001 in both sites). The effect was more marked in the low transmission area where more than 90% of the patients received appropriately targeted treatment in the mRDT arm. This could be attributable to the combination of high specificity of mRDT in a setting of low and unstable malaria transmission, where nearly 100% of mRDT negatives were negative by light microscopy, and high adherence to mRDT results by CHWs. In contrast, where CHWs followed presumptive diagnosis, more than 90% of patients subsequently found to be slide negative had received an unnecessary ACT treatment. This concurs with previous reports that overuse of ACTs is likely to be higher in areas with low malaria prevalence <xref rid="tmi12748-bib-0016" ref-type="ref">16</xref>, <xref rid="tmi12748-bib-0017" ref-type="ref">17</xref>. A high degree of adherence to test results by CHWs has frequently been observed in studies among CHWs, in contrast to the less favourable reports from research among health facility&#x02010;based providers and some other community programmes <xref rid="tmi12748-bib-0018" ref-type="ref">18</xref>, <xref rid="tmi12748-bib-0019" ref-type="ref">19</xref>, <xref rid="tmi12748-bib-0020" ref-type="ref">20</xref>, <xref rid="tmi12748-bib-0021" ref-type="ref">21</xref>, <xref rid="tmi12748-bib-0022" ref-type="ref">22</xref>, <xref rid="tmi12748-bib-0023" ref-type="ref">23</xref>. Factors which may have contributed to high adherence in our trial were the comprehensive and participatory training that CHWs received, including clear guidance on referral criteria and how to handle RDT&#x02010;negative patients, and community meetings to create awareness that not all fevers are due to malaria and explain the rationale for diagnostic testing at community level. Furthermore, the use of job aids, previously found to be an important aid for CHWs to interpret and adhere to mRDT results <xref rid="tmi12748-bib-0023" ref-type="ref">23</xref>, and supportive supervision during the immediate post&#x02010;training period, may have sustained the awareness and adherence to guidelines <xref rid="tmi12748-bib-0024" ref-type="ref">24</xref> and enhanced CHWs self&#x02010;esteem and confidence in what they were doing. Educative interaction between caretakers and health workers has been shown to be a major factor for community acceptability of RDT use <xref rid="tmi12748-bib-0025" ref-type="ref">25</xref>. Close proximity of CHWs to other members of the community, coupled with community sensitisation and the communication training provided to CHWs as part of the intervention, may also have facilitated high adherence to mRDT results by CHWs.</p><p>More than 80% of patients with fever in the intervention and control arms in both transmission settings consulted CHWs for treatment within 24 h after onset of symptoms, which is much higher than has previously been observed at health facilities in Uganda <xref rid="tmi12748-bib-0011" ref-type="ref">11</xref> and elsewhere <xref rid="tmi12748-bib-0026" ref-type="ref">26</xref>. These data show that CHWs provide an opportunity for improving the speed of treatment seeking for febrile illnesses in rural areas, where poor access to health facilities, lack of drugs, perceived high cost and unfriendly attitude of health workers often result in delayed treatment <xref rid="tmi12748-bib-0027" ref-type="ref">27</xref>, <xref rid="tmi12748-bib-0028" ref-type="ref">28</xref>, <xref rid="tmi12748-bib-0029" ref-type="ref">29</xref>, <xref rid="tmi12748-bib-0030" ref-type="ref">30</xref>, <xref rid="tmi12748-bib-0031" ref-type="ref">31</xref>, <xref rid="tmi12748-bib-0032" ref-type="ref">32</xref> and illustrate the role of community&#x02010;based treatment programmes in increasing access to prompt effective treatment of malaria.</p><p>The sensitivity of mRDTs in this study was lower than has been previously observed among CHWs <xref rid="tmi12748-bib-0023" ref-type="ref">23</xref>, particularly in the low malaria area, which could be due to the large proportion of low parasite density infections observed in those patients who were untreated, and which may therefore have been undetected by mRDT <xref rid="tmi12748-bib-0033" ref-type="ref">33</xref>, <xref rid="tmi12748-bib-0034" ref-type="ref">34</xref>. Blood slides were prepared by CHWs, which was found to be a particular limitation in our study and others <xref rid="tmi12748-bib-0014" ref-type="ref">14</xref>, and reduced the number of samples examined by microscopy and thus available for analysis, especially in the low transmission area. Nonetheless, the characteristics of patients included in the final analysis and CHWs were comparable between arms and we do not consider our findings could be attributed to selection bias. The mRDTs used passed independent quality&#x02010;assurance batch testing, and we can confidently exclude test performance as a reason for low sensitivity. As the majority of false negatives were low&#x02010;density infections, we can also exclude the possibility that this was due to a prozone effect; though the frequency of HRP&#x02010;2 deletions in this population is unknown <xref rid="tmi12748-bib-0035" ref-type="ref">35</xref>. Other possible causes for false&#x02010;negative mRDT results include operator error, especially where a CHW works under poor lighting conditions and/or at night <xref rid="tmi12748-bib-0035" ref-type="ref">35</xref>. Nonetheless, as missed treatment was frequently observed in low&#x02010;density infection, below the acknowledged limit of detection of most mRDTs, we consider this to be the most likely cause for this observation. False positives were higher in the high transmission area than in the low transmission area, as would be expected due to persistent antigenaemia in individuals recently infected by malaria in hyperendemic areas <xref rid="tmi12748-bib-0036" ref-type="ref">36</xref>.</p><p>The benefits of using mRDTs to improve targeting of ACTs and limit their overuse need to be weighed against the risks of not treating an infected child <xref rid="tmi12748-bib-0037" ref-type="ref">37</xref>. Among semi&#x02010;immune children with low parasite counts in the moderate&#x02010;to&#x02010;high transmission area, the probability that the fever is attributable to malaria is low <xref rid="tmi12748-bib-0038" ref-type="ref">38</xref>, <xref rid="tmi12748-bib-0039" ref-type="ref">39</xref>, and antimalarial treatment is not necessarily required. However, missed treatment in non&#x02010;immune subjects in the low transmission area is of greater potential concern. A limitation of this study was that we did not follow up patients to see if they recovered so we do not know the clinical outcome in those who missed receiving treatment when they were mRDT negative but proved to be parasite&#x02010;positive on microscopy. Poor sensitivity of HRP&#x02010;2&#x02010;based mRDTs has previously been reported from other areas of low transmission <xref rid="tmi12748-bib-0033" ref-type="ref">33</xref>, <xref rid="tmi12748-bib-0034" ref-type="ref">34</xref>, and more sensitive point&#x02010;of&#x02010;care diagnostic techniques, of low cost and suitable for routine use in these low transmission settings, are needed. Thus, before scaling up mRDT use by CHWs in low transmission areas, we would suggest that safety studies with follow&#x02010;up data on patients who missed treatment due low sensitivity of current mRDTs be conducted to adequately assess the risk of non&#x02010;treatment of low&#x02010;density infections in non&#x02010;immunes. It is conceivable that missed treatments are more frequent in community&#x02010;based programmes than in other health services using mRDTs, as patients may be more likely to seek care at an earlier stage in their illness. Parasite density among patients presenting to CHWs may therefore be lower than in patients who first present to health facilities, and a greater proportion of them may have an infection below the detection threshold of current mRDTs, irrespective of local transmission intensity. Encouraging patients with no symptoms other than fever, who test mRDT negative, to return to the CHW for re&#x02010;evaluation and retesting whether symptoms do not improve, could help mitigate the risk of not treating an infected child.</p></sec><sec id="tmi12748-sec-0020"><title>Conclusion</title><p>The findings presented here underscore the value of mRDT&#x02010;based diagnosis of malaria in reducing overuse of ACTs in community case management and should be of particular interest to malaria programme managers and policymakers, nationally, regionally and internationally as countries scale up iCCM <xref rid="tmi12748-bib-0040" ref-type="ref">40</xref>. Equipping CHWs with mRDTs markedly improved the appropriate targeting of ACT treatment. With increased financing for malaria and large&#x02010;scale control, the prevalence of malaria should reduce and the potential role of mRDTs in targeting malaria treatment and disease surveillance will become ever more critical <xref rid="tmi12748-bib-0041" ref-type="ref">41</xref> at all levels of health service delivery, including community level. Use of mRDTs and diagnostic algorithms has the additional potential to also improve detection and treatment of non&#x02010;malaria fevers. Our data show mRDT use was beneficial in improving the targeting of ACT use in both moderate&#x02010;to&#x02010;high and low transmission areas and that a widespread adoption of mRDTs at community level can reduce misdiagnosis and inappropriate treatment of febrile illness in all malaria transmission settings. Nonetheless, mRDTs have several limitations that may reduce their utility in low transmission settings because they do not reliably detect low&#x02010;density parasitaemia. Studies have shown that in infants, parasitaemia is synonymous to clinical malaria <xref rid="tmi12748-bib-0042" ref-type="ref">42</xref>. Therefore, missed treatments due to the low sensitivity of current mRDTs to low&#x02010;density infections (as reported here and in other areas of low transmission <xref rid="tmi12748-bib-0034" ref-type="ref">34</xref>) are a concern and suggest that despite the potential cost savings from reduced use of ACTs, presumptive diagnosis and treatment of all fevers as malaria may remain advisable in malarious areas where populations have little or no immunity, until such time as more sensitive diagnostic assays become widely available.</p></sec></body><back><ack id="tmi12748-sec-0021"><title>Acknowledgements</title><p>The authors wish to acknowledge the participation of CHWs who treated children that consulted them with fever during the study period; the valuable contribution of the laboratory technicians who performed the microscopy (Dickson Birakwate, Phiona Kafuko, Betty Nabatte, Anna Mary Auma and Annet Enzaru); Clare Chandler who helped develop the intervention, Carolyn Lynch who helped develop the training materials and Bonnie Cundill for statistical advice. This work was supported by the ACT Consortium, funded through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. Sian Clarke was supported by the Wellcome Trust through a Research Career Development Fellowship (084933).</p></ack><ref-list content-type="cited-references" id="tmi12748-bibl-0001"><title>References</title><ref id="tmi12748-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="tmi12748-cit-0001">
<collab collab-type="authors">World Health Organisation</collab>
. <article-title>Implementation of the Global malaria control strategy. Report of a WHO study group on the implementation of the global plan of action for malaria control 1993&#x02013;2000</article-title>. <source>World Health Organ Tech Rep Ser</source>
<year>1993</year>: <volume>839</volume>: <fpage>1</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">8284937</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0002"><label>2</label><mixed-citation publication-type="book" id="tmi12748-cit-0002">
<collab collab-type="authors">World Health Organisation</collab>
. <source>Guidelines for the Treatment of Malaria</source>, <edition>2nd edn</edition>
<publisher-name>WHO</publisher-name>: <publisher-loc>Geneva</publisher-loc>, <year>2010</year>
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html">http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html</ext-link>
</mixed-citation></ref><ref id="tmi12748-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="tmi12748-cit-0003">
<string-name>
<surname>Marsh</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Hamer</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Pagnoni</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>S</given-names>
</string-name>. <article-title>Introduction to a special supplement: evidence for implementation, effects, and impact of integrated community case management strategy to treat childhood infection</article-title>. <source>Am J Trop Med Hyg</source>
<year>2011</year>: <volume>87</volume>(<issue>Suppl. 5</issue>): <fpage>2</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">23136271</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="tmi12748-cit-0004">
<string-name>
<surname>D'Acremont</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lengeler</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mshinda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mtasiwa</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tanner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Genton</surname>
<given-names>B</given-names>
</string-name>. <article-title>Time to move from presumptive malaria treatment to laboratory&#x02010;confirmed diagnosis and treatment in African children with fever</article-title>. <source>PLoS Med</source>
<year>2009</year>: <volume>6</volume>: <fpage>e252</fpage>.<pub-id pub-id-type="pmid">19127974</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="tmi12748-cit-0005">
<string-name>
<surname>Harvey</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Jennings</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chinyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Masaninga</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mulholland</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>DR</given-names>
</string-name>. <article-title>Improving community health worker use of malaria rapid diagnostic tests in Zambia: package instructions, job aid and aid&#x02010;plus&#x02010;training</article-title>. <source>Malaria J</source>
<year>2008</year>: <volume>7</volume>: <fpage>160</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="tmi12748-cit-0006">
<string-name>
<surname>Ukwaja</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Ainna</surname>
<given-names>OB</given-names>
</string-name>, <string-name>
<surname>Talabi</surname>
<given-names>AA</given-names>
</string-name>. <article-title>Clinical overlap between malaria and pneumonia: can malaria rapid diagnostic test play a role?</article-title>
<source>J Infect Dev Count</source>
<year>2011</year>: <volume>5</volume>: <fpage>199</fpage>&#x02013;<lpage>203</lpage>.</mixed-citation></ref><ref id="tmi12748-bib-0007"><label>7</label><mixed-citation publication-type="book" id="tmi12748-cit-0007">
<collab collab-type="authors">World Health Organization</collab>
. <source>Universal Access to Malaria Diagnostic Testing. An Operational Manual</source>. <publisher-name>WHO</publisher-name>: <publisher-loc>Geneva</publisher-loc>, <year>2011</year>.</mixed-citation></ref><ref id="tmi12748-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="tmi12748-cit-0008">
<string-name>
<surname>Chandramohan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Carneiro</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Kavishwar</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity</article-title>. <source>Tropical Med Int Health</source>
<year>2001</year>: <volume>6</volume>: <fpage>505</fpage>&#x02013;<lpage>510</lpage>.</mixed-citation></ref><ref id="tmi12748-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="tmi12748-cit-0009">
<string-name>
<surname>Lemma</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Byass</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Desta</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic>
<article-title>Deploying artemether&#x02010;lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources</article-title>. <source>Tropical Med Int Health</source>
<year>2010</year>: <volume>15</volume>: <fpage>241</fpage>&#x02013;<lpage>250</lpage>.</mixed-citation></ref><ref id="tmi12748-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="tmi12748-cit-0010">
<string-name>
<surname>Yeboah&#x02010;Antwi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Piligana</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Macloed</surname>
<given-names>WB</given-names>
</string-name>
<italic>et al</italic>
<article-title>Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial</article-title>. <source>PLoS Med</source>
<year>2010</year>: <volume>7</volume>: <fpage>e1000340</fpage>.<pub-id pub-id-type="pmid">20877714</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0011"><label>11</label><mixed-citation publication-type="book" id="tmi12748-cit-0011">
<collab collab-type="authors">Uganda Bureau of Statistics (UBOS) and ICF Macro</collab>
. <source>Uganda Malaria Indicator Survey 2009</source>. <publisher-name>UBOS and ICF Macro</publisher-name>: <publisher-loc>Calverton, Maryland, USA</publisher-loc>, <year>2010</year>.</mixed-citation></ref><ref id="tmi12748-bib-0012"><label>12</label><mixed-citation publication-type="book" id="tmi12748-cit-0012">
<collab collab-type="authors">USAID Quality Assurance Project and World Health Organization</collab>
. <source>How to Use a Rapid Diagnostic Test (RDT): A Guide for Training at a Village and Clinic Level (Modified for Training in the Use of the Generic Pf Test for Falciparum Malaria)</source>. <publisher-name>WHO</publisher-name>: <publisher-loc>Bethesda, MD, and Geneva</publisher-loc>, <year>2008</year>.</mixed-citation></ref><ref id="tmi12748-bib-0013"><label>13</label><mixed-citation publication-type="book" id="tmi12748-cit-0013">
<string-name>
<surname>Hayes</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Moulton</surname>
<given-names>L</given-names>
</string-name>. <source>Cluster randomised trials</source>. <publisher-name>CRC Press</publisher-name>: <publisher-loc>London</publisher-loc>, <year>2009</year>.</mixed-citation></ref><ref id="tmi12748-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="tmi12748-cit-0014">
<string-name>
<surname>Mubi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Janson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Warsame</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross&#x02010;over trial in Tanzania</article-title>. <source>PLoS ONE</source>
<year>2011</year>: <volume>6</volume>: <fpage>e19753</fpage>.<pub-id pub-id-type="pmid">21750697</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="tmi12748-cit-0015">
<string-name>
<surname>Rutta</surname>
<given-names>ASM</given-names>
</string-name>, <string-name>
<surname>Francis</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mmbando</surname>
<given-names>BP</given-names>
</string-name>
<italic>et al</italic>
<article-title>Using community&#x02010;owned resource persons to provide early diagnosis and treatment and estimate malaria burden at community level in north&#x02010;eastern Tanzania</article-title>. <source>Malaria J</source>
<year>2012</year>: <volume>11</volume>: <fpage>152</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="tmi12748-cit-0016">
<string-name>
<surname>Lubell</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Reyburn</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mbakilwa</surname>
<given-names>H</given-names>
</string-name>
<italic>et al</italic>
<article-title>The impact of response to the results of diagnostic tests for malaria: cost&#x02010;benefit analysis</article-title>. <source>BMJ</source>
<year>2008</year>: <volume>336</volume>: <fpage>202</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">18199700</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="tmi12748-cit-0017">
<string-name>
<surname>Shillcutt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Morel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Goodman</surname>
<given-names>C</given-names>
</string-name>
<italic>et al</italic>
<article-title>Cost&#x02010;effectiveness of malaria diagnostic methods in sub&#x02010;Saharan Africa in an era of combination therapy</article-title>. <source>Bull World Health Org</source>
<year>2009</year>: <volume>86</volume>: <fpage>101</fpage>&#x02013;<lpage>110</lpage>.<pub-id pub-id-type="pmid">18297164</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="tmi12748-cit-0018">
<string-name>
<surname>Chinkumba</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Skarbinski</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chilima</surname>
<given-names>B</given-names>
</string-name>
<italic>et al</italic>
<article-title>Comparative field performance and adherence to test results of four malaria rapid diagnostic tests among febrile patients more than five year of age in Blantyre, Malawi</article-title>. <source>Malaria J</source>
<year>2010</year>: <volume>9</volume>: <fpage>209</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="tmi12748-cit-0019">
<string-name>
<surname>Mukanga</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Babirye</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>Can lay community workers be trained to use diagnostics to distinguish and treat malaria and pneumonia in children? Lessons from rural Uganda</article-title>. <source>Tropical Med Int Health</source>
<year>2011</year>: <volume>16</volume>: <fpage>1234</fpage>&#x02013;<lpage>1242</lpage>.</mixed-citation></ref><ref id="tmi12748-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="tmi12748-cit-0020">
<string-name>
<surname>Uzochukwu</surname>
<given-names>BSC</given-names>
</string-name>, <string-name>
<surname>Onwujekwe</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ezuma</surname>
<given-names>NN</given-names>
</string-name>, <string-name>
<surname>Ezeoke</surname>
<given-names>OP</given-names>
</string-name>, <string-name>
<surname>Ajuba</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>Sibeudu</surname>
<given-names>FT</given-names>
</string-name>. <article-title>Improving rational treatment of malaria: perceptions and influence of RDTs on prescribing behaviour of health workers in Southeast Nigeria</article-title>. <source>PLoS ONE</source>
<year>2011</year>: <volume>6</volume>: <fpage>e14627</fpage>.<pub-id pub-id-type="pmid">21297938</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="tmi12748-cit-0021">
<string-name>
<surname>Kabaghe</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Visser</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Spijker</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Phiri</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Grobusch</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>van Vugt</surname>
<given-names>M</given-names>
</string-name>. <article-title>Health workers' compliance to rapid diagnostic tests (RDTs) to guide malaria treatment: a systematic review and meta&#x02010;analysis</article-title>. <source>Malaria J</source>
<year>2016</year>: <volume>15</volume>: <fpage>163</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="tmi12748-cit-0022">
<string-name>
<surname>Mukanga</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tiono</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Anyorigiya</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic>
<article-title>Integrated community case management of fever in children under five using rapid diagnostic tests and respiratory rate counting: a multi&#x02010;country cluster randomized trial</article-title>. <source>Am J Trop Med Hyg</source>
<year>2012</year>: <volume>87</volume>: <fpage>21</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">23136274</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="tmi12748-cit-0023">
<string-name>
<surname>Ruizendaal</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Dierickx</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Grietens</surname>
<given-names>KP</given-names>
</string-name>, <string-name>
<surname>Schallig</surname>
<given-names>HDFH</given-names>
</string-name>, <string-name>
<surname>Pagnoni</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mens</surname>
<given-names>PF</given-names>
</string-name>. <article-title>Success or failure of critical steps in community case management of malaria with rapid diagnostic tests: a systematic review</article-title>. <source>Malaria J</source>
<year>2014</year>: <volume>13</volume>: <fpage>229</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="tmi12748-cit-0024">
<string-name>
<surname>Staedke</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Mwebaza</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kamya</surname>
<given-names>MR</given-names>
</string-name>
<italic>et al</italic>
<article-title>Home management of malaria with artemether&#x02010;lumefantrine compared with standard care in urban Ugandan children: a randomized controlled trial</article-title>. <source>Lancet</source>
<year>2009</year>: <volume>373</volume>: <fpage>1623</fpage>&#x02013;<lpage>1631</lpage>.<pub-id pub-id-type="pmid">19362361</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="tmi12748-cit-0025">
<string-name>
<surname>Baiden</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Owusu&#x02010;Agyenyi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Okyere</surname>
<given-names>E</given-names>
</string-name>
<italic>et al</italic>
<article-title>Acceptability of rapid diagnostic test&#x02010;based management of Malaria among caregivers of under&#x02010;five children in rural Ghana</article-title>. <source>PLoS ONE</source>
<year>2012</year>: <volume>9</volume>: <fpage>e45556</fpage>.<pub-id pub-id-type="pmid">23029094</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="tmi12748-cit-0026">
<string-name>
<surname>Gitonga</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Amin</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Ajanga</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kangwana</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Noor</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Snow</surname>
<given-names>RW</given-names>
</string-name>. <article-title>The use of artemether&#x02010;lumefantrine by febrile children following national implementation of a revised drug policy in Kenya</article-title>. <source>Tropical Med Int Health</source>
<year>2008</year>: <volume>13</volume>: <fpage>487</fpage>&#x02013;<lpage>494</lpage>.</mixed-citation></ref><ref id="tmi12748-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="tmi12748-cit-0027">
<string-name>
<surname>D'Ambruoso</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Abbey</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hussein</surname>
<given-names>J</given-names>
</string-name>. <article-title>&#x0201c;Please understand when I cry out in pain&#x0201d;: women's accounts of maternity services during labour and delivery in Ghana</article-title>. <source>BMC Public Health</source>
<year>2005</year>: <volume>5</volume>: <fpage>140</fpage>.<pub-id pub-id-type="pmid">16372911</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="tmi12748-cit-0028">
<string-name>
<surname>Deressa</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>A</given-names>
</string-name>. <article-title>Malaria&#x02010;related perceptions and practices of women with children under the age of five years in rural Ethiopia</article-title>. <source>BMC Public Health</source>
<year>2009</year>: <volume>9</volume>: <fpage>259</fpage>.<pub-id pub-id-type="pmid">19627572</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="tmi12748-cit-0029">
<string-name>
<surname>Kiwanuka</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Ekirapa</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence</article-title>. <source>Trans R Soc Trop Med Hyg</source>
<year>2008</year>: <volume>102</volume>: <fpage>1067</fpage>&#x02013;<lpage>1074</lpage>.<pub-id pub-id-type="pmid">18565559</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="tmi12748-cit-0030">
<string-name>
<surname>Kpanake</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Dassa</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>E</given-names>
</string-name>. <article-title>Why most Tongolese people do not seek care for malaria in health care facilities: a theory&#x02010;driven inventory of reasons</article-title>. <source>Psychol Health Med</source>
<year>2009</year>: <volume>14</volume>: <fpage>502</fpage>&#x02013;<lpage>510</lpage>.<pub-id pub-id-type="pmid">19697259</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="tmi12748-cit-0031">
<string-name>
<surname>Ndyomugyenyi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Neema</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Magnussen</surname>
<given-names>P</given-names>
</string-name>. <article-title>The use of formal and informal services for antenatal care and malaria treatment in rural Uganda</article-title>. <source>Health Policy Plan</source>
<year>1998</year>: <volume>13</volume>: <fpage>94</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="pmid">10178189</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="tmi12748-cit-0032">
<string-name>
<surname>Rutebemberwa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nsabagasani</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Pariyo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tomson</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Peterson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kallander</surname>
<given-names>K</given-names>
</string-name>. <article-title>Use of drugs, perceived drug efficacy and preferred providers for febrile children: implications for home management of fever</article-title>. <source>Malaria J</source>
<year>2005</year>: <volume>8</volume>: <fpage>31</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="tmi12748-cit-0033">
<string-name>
<surname>McMorrow</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Aidoo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kachur</surname>
<given-names>P</given-names>
</string-name>. <article-title>Malaria rapid diagnostic tests in elimination settings&#x02010;can they find the last parasite?</article-title>
<source>Clin Microbiol Inf</source>
<year>2011</year>: <volume>17</volume>: <fpage>1624</fpage>&#x02013;<lpage>1631</lpage>.</mixed-citation></ref><ref id="tmi12748-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="tmi12748-cit-0034">
<string-name>
<surname>Shakely</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Elfving</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Aydin&#x02010;Scmidt</surname>
<given-names>B</given-names>
</string-name>
<italic>et al</italic>
<article-title>The usefulness of rapid diagnostic tests in the new context of low malaria transmission in Zanzibar</article-title>. <source>PLoS ONE</source>
<year>2013</year>: <volume>8</volume>: <fpage>e72912</fpage>.<pub-id pub-id-type="pmid">24023791</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="tmi12748-cit-0035">
<string-name>
<surname>Maltha</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gillet</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>J</given-names>
</string-name>. <article-title>Review: malaria rapid diagnostic tests in endemic settings</article-title>. <source>Clin Microbiol Infect</source>
<year>2013</year>: <volume>19</volume>: <fpage>399</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="pmid">23438048</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="tmi12748-cit-0036">
<string-name>
<surname>Kybabayinze</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Tibenderana</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Odong</surname>
<given-names>GW</given-names>
</string-name>, <string-name>
<surname>Rwakimari</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Counihan</surname>
<given-names>H</given-names>
</string-name>. <article-title>Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for <italic>Plasmodium falciparum</italic> malaria in a hyperendemic region of Uganda</article-title>. <source>Malaria J</source>
<year>2008</year>: <volume>29</volume>: <fpage>221</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="tmi12748-cit-0037">
<string-name>
<surname>Bj&#x000f6;rkman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>M&#x000e5;rtensson</surname>
<given-names>A</given-names>
</string-name>. <article-title>Risks and benefits of targeted malaria treatment based on rapid diagnostic test results</article-title>. <source>Clin Infect Dis</source>
<year>2010</year>: <volume>51</volume>: <fpage>512</fpage>&#x02013;<lpage>514</lpage>.<pub-id pub-id-type="pmid">20642355</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="tmi12748-cit-0038">
<string-name>
<surname>Armstrong&#x02010;Schellenberg</surname>
<given-names>JRM</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Alonso</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>Hayes</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>What is clinical malaria? Finding case definitions for field research in highly endemic areas</article-title>. <source>Parasitology Today</source>
<year>1994</year>: <volume>10</volume>: <fpage>439</fpage>&#x02013;<lpage>442</lpage>.<pub-id pub-id-type="pmid">15275531</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="tmi12748-cit-0039">
<string-name>
<surname>Bolond</surname>
<given-names>PB</given-names>
</string-name>, <string-name>
<surname>Boriga</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Ruebush</surname>
<given-names>YK</given-names>
</string-name>
<italic>et al</italic>
<article-title>Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children</article-title>. <source>Am J Trop Med Hyg</source>
<year>1999</year>: <volume>60</volume>: <fpage>641</fpage>&#x02013;<lpage>648</lpage>.<pub-id pub-id-type="pmid">10348241</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="tmi12748-cit-0040">
<string-name>
<surname>Young</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Walfheim</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Hammamy</surname>
<given-names>D</given-names>
</string-name>. <article-title>World Health Organization/United Nations Children's Fund Joint Statement on Integrated Community Case Management: An Equity Focussed Strategy to Improve Access to Essential Treatment Services for Children</article-title>. <source>Am J Trop Med Hyg</source>
<year>2012</year>: <volume>87</volume>(<issue>Suppl. 5</issue>): <fpage>6</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">23136272</pub-id></mixed-citation></ref><ref id="tmi12748-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="tmi12748-cit-0041">
<string-name>
<surname>Perkins</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>D</given-names>
</string-name>. <article-title>Working without a blindfold: the critical role of diagnosis is essential to achieving long term goals</article-title>. <source>Malaria J</source>
<year>2008</year>: <volume>7</volume> (<issue>Suppl 1</issue>): <fpage>S5</fpage>.</mixed-citation></ref><ref id="tmi12748-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="tmi12748-cit-0042">
<string-name>
<surname>McGuinness</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Koram</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nkrumah</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>E</given-names>
</string-name>. <article-title>Clinical case definition for malaria: clinical malaria associated with very low parasite densities in African children</article-title>. <source>Trans R Soc Trop Med Hyg</source>
<year>1998</year>: <volume>92</volume>: <fpage>527</fpage>&#x02013;<lpage>531</lpage>.<pub-id pub-id-type="pmid">9861370</pub-id></mixed-citation></ref></ref-list></back></article>